Pfizer’s New Strategy Head Grapples With Some Blockbuster Problems
Recently recruited from his analyst post, Andrew Baum is now Pfizer’s head of strategy and is having to deal with some big decisions on R&D investment and long-term commercial bets.
Recently recruited from his analyst post, Andrew Baum is now Pfizer’s head of strategy and is having to deal with some big decisions on R&D investment and long-term commercial bets.